Expression of apoptosis-related genes in chronic cyclosporine nephrotoxicity in mice

被引:74
作者
Yang, CW [1 ]
Faulkner, GR
Wahba, IM
Christianson, TA
Bagby, GC
Jin, DC
Abboud, HE
Andoh, TF
Bennett, WM
机构
[1] Catholic Univ Korea, Div Nephrol, Seoul, South Korea
[2] Oregon Hlth & Sci Univ, Div Nephrol Hypertens & Clin Pharmacol, Portland, OR USA
[3] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR USA
[4] Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX USA
关键词
apoptosis; cyclosporine; mice;
D O I
10.1034/j.1600-6143.2002.20501.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
To define the mechanism of cyclosporine (CsA)-induced apoptosis, we investigated the expression of apoptosis-related genes in experimental chronic CsA nephrotoxicity. Mice on a low-salt (0.01%) diet were given vehicle (VH, olive oil, 1 mg/kg/day), or CsA (30 mg/kg/day), and sacrificed at 1 and 4 weeks. Apoptosis was detected with deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) stain, and the expressions of apoptosis-related genes were evaluated by reverse transcription-polymerase chain reaction, immunoblot or immunohistochemistry. The activity of caspase 1 and 3 was also evaluated. The CsA group showed increases in apoptotic cells compared with the VH group (54 +/- 41 vs. 3 +/- 3, p < 0.05), and the number of apoptotic cells correlated well with interstitial fibrosis scores (r =0.83, p < 0.01). The CsA group showed a significant increase in Fas-ligand mRNA (0.20 vs. 0.02 amol/mug total RNA, p < 0.05) and Fas protein expression (146% vs. 95%, p < 0.05), compared with the VH group. The CsA group showed significant increases in ICE mRNA (0.21 vs. 0.03 amol/mug total RNA at 4 weeks, p < 0.05) and CPP32 mRNA (0.18 vs. 0.03 amol/mug total RNA at 4 weeks, p < 0.05), compared with the VH group. The enzymatic activity of ICE (16.6 vs. 7.9 rhomol/mug/h, p < 0.06) and CPP32 protease (15.6 vs. 2.7 rhomol/mug/h, p < 0.05) proteases were increased in the CsA group, compared with the VH group. The ratio between bax and bcl-2 protein increased significantly in the CsA group (5.3-fold), compared with the VH group. Levels of p53 protein also increased in the CsA group. Immunohistochemical detection of Fas, Fas-ligand, ICE and CPP32 revealed strong immunoreactivity in renal tubular cells in areas of structural injury. These findings suggest that local activation of the apoptosis-related genes is associated with CsA-induced apoptotic cell death.
引用
收藏
页码:391 / 399
页数:9
相关论文
共 47 条
  • [21] P53 IS REQUIRED FOR RADIATION-INDUCED APOPTOSIS IN MOUSE THYMOCYTES
    LOWE, SW
    SCHMITT, EM
    SMITH, SW
    OSBORNE, BA
    JACKS, T
    [J]. NATURE, 1993, 362 (6423) : 847 - 849
  • [22] MIYASHITA T, 1995, CELL, V80, P293
  • [23] MIYASHITA T, 1994, ONCOGENE, V9, P1799
  • [24] MIYASHITA T, 1994, CANCER RES, V54, P3131
  • [25] Bcl-2 overexpression blocks activation of the death protease CPP32/Yama/apopain
    Monney, L
    Otter, I
    Olivier, R
    Ravn, U
    Mirzasaleh, H
    Fellay, I
    Poirier, GG
    Borner, C
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (02) : 340 - 345
  • [26] IDENTIFICATION AND INHIBITION OF THE ICE/CED-3 PROTEASE NECESSARY FOR MAMMALIAN APOPTOSIS
    NICHOLSON, DW
    ALI, A
    THORNBERRY, NA
    VAILLANCOURT, JP
    DING, CK
    GALLANT, M
    GAREAU, Y
    GRIFFIN, PR
    LABELLE, M
    LAZEBNIK, YA
    MUNDAY, NA
    RAJU, SM
    SMULSON, ME
    YAMIN, TT
    YU, VL
    MILLER, DK
    [J]. NATURE, 1995, 376 (6535) : 37 - 43
  • [27] Nogae S, 1998, J AM SOC NEPHROL, V9, P620
  • [28] INDUCTION OF APOPTOSIS IN CULTURED-HEPATOCYTES AND IN REGRESSING LIVER BY TRANSFORMING GROWTH FACTOR-BETA-1
    OBERHAMMER, FA
    PAVELKA, M
    SHARMA, S
    TIEFENBACHER, R
    PURCHIO, AF
    BURSCH, W
    SCHULTEHERMANN, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) : 5408 - 5412
  • [29] BCL-2 HETERODIMERIZES IN-VIVO WITH A CONSERVED HOMOLOG, BAX, THAT ACCELERATES PROGRAMMED CELL-DEATH
    OLTVAI, ZN
    MILLIMAN, CL
    KORSMEYER, SJ
    [J]. CELL, 1993, 74 (04) : 609 - 619
  • [30] Ortiz A, 1997, J INVEST MED, V45, P50